Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Use of T-VEC in early metastatic melanoma

Source: Ecancer, November 2018 Ms Viola Franke – Netherlands Cancer Institute, Amsterdam, Netherlands Viola Franke speaks with ecancer at ESMO 2018 in Munich about results from a trial using engineered virotherapy talimogene laherparepvec (T-VEC) in early metastatic melanoma. She describes the significant response rates and low toxicity in this early trial, with followups planned to monitor the […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Immunotherapy Combos: Will Cost Put Them out of Reach?

Source: Medscape, November 2018 WASHINGTON — New classes of cancer medicines that activate the immune system may be used in combinations, just as more traditional chemotherapies have been, specialists said here at the 2018 annual meeting of the National Academy of Medicine. However, the prospect of using combinations of these immunotherapies will exacerbate already intense […]

READ MORE >

Posted in Melanoma News, Health Professionals, Patients, Latest News, Of Interest

Medicare to Cover Castle Bio’s Cutaneous Melanoma Test

Source: Genome Web, November 2018 NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA on Thursday issued a final local coverage determination for Castle Biosciences’ DecisionDx-Melanoma assay, a prognostic test for cutaneous melanoma that helps guide use of sentinel lymph node biopsy (SLNB). The LCD extends coverage of the assay for SLNB-eligible patients with T1 and T2 cutaneous […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Puzanov Provides Perspective on T-VEC in Melanoma

Source: OncLive, November 2018 In 2015, talimogene laherparepvec (T-VEC; Imlygic) became the first-in-class oncolytic immunotherapy to be FDA approved for the treatment of advanced-stage unresectable melanoma, but its path forward may be in combination with checkpoint inhibitors, explained Igor Puzanov, MD, MSCI, FACP. In the phase III OPTiM trial, which was the basis for the […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest